SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: SCT-I10A+chemo; Drug: Placebos+chemo Sponsor: Sinocelltech Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | HNSCC | Research | Skin Cancer | Squamous Cell Carcinoma